Back to User profile » Dr Pijian YANG

Papers published by Dr Pijian YANG:


Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways

Luo Y, Yang P, Li Z, Luo Y, Shen J, Li R, Zheng H, Liang Y, Xia N

Drug Design, Development and Therapy 2019, 13:4065-4074

Published Date: 2 December 2019

Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway

Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H

Diabetes, Metabolic Syndrome and Obesity 2019, 12:1697-1703

Published Date: 3 September 2019

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

Yang P, Liang Y, Luo Y, Li Z, Wen Y, Shen J, Li R, Zheng H, Gu HF, Xia N

Diabetes, Metabolic Syndrome and Obesity 2019, 12:1013-1021

Published Date: 4 July 2019

Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia

Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, Yang P, Chatterjee R, Liang Y

Diabetes, Metabolic Syndrome and Obesity 2019, 12:457-468

Published Date: 11 April 2019